{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:58:54Z","timestamp":1760403534759,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijantimicag.2019.105861","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T20:13:12Z","timestamp":1576181592000},"page":"105861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model"],"prefix":"10.1016","volume":"55","author":[{"given":"Narayana","family":"Garimella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tesfalem","family":"Zere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aschalew","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.105861_bib0001","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41564-019-0531-5","article-title":"Phylogenetic reconciliation reveals the natural history of glycopeptide antibiotic biosynthesis and resistance","volume":"4","author":"Waglechner","year":"2019","journal-title":"Nat Microbiol"},{"year":"2017","series-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","key":"10.1016\/j.ijantimicag.2019.105861_bib0002"},{"year":"2013","series-title":"Antibiotic resistance threats in the United States, 2013","key":"10.1016\/j.ijantimicag.2019.105861_bib0003"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.348.6237.850","article-title":"The drug push","volume":"348","author":"Servick","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0006","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance\u2014the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0007","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.37.9.1756","article-title":"Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection","volume":"37","author":"Marchbanks","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0008","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1128\/AAC.03505-14","article-title":"Evaluation of meropenem regimens suppressing the emergence of Acinetobacter baumannii with human-simulated exposure in an in vitro intravenous-infusion hollow-fiber infection model","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211214","article-title":"Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus","volume":"14","author":"Broussou","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0010","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/AAC.00752-15","article-title":"Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance","volume":"59","author":"Docobo-P\u00e9rez","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0011","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/iai.58.5.1281-1289.1990","article-title":"Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains","volume":"58","author":"Mobley","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0012","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1073\/pnas.252529799","article-title":"Extensive mosaic structure revealed by the complete genome sequence of a uropathogenic Escherichia coli","volume":"99","author":"Welch","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"year":"2019","series-title":"Performance standards for antimicrobial susceptibility testing","key":"10.1016\/j.ijantimicag.2019.105861_bib0013"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0014","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3389\/fmicb.2018.00572","article-title":"Differential activity of the combination of vancomycin and amikacin on planktonic vs. biofilm-growing Staphylococcus aureus bacteria in a hollow fiber infection model","volume":"9","author":"Broussou","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.coph.2011.07.009","article-title":"Optimizing dosage to prevent emergence of resistance\u2014lessons from in vitro models","volume":"11","author":"Singh","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpba.2011.09.024","article-title":"Simultaneous determination of flucloxacillin and ampicillin in human plasma by ultra performance liquid chromatography\u2013tandem mass spectrometry and subsequent application to a clinical study in healthy Chinese volunteers","volume":"59","author":"Huang","year":"2012","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0017","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jchromb.2007.05.037","article-title":"Rapid and selective liquid chromatographic\/tandem mass spectrometric method for the determination of fosfomycin in human plasma","volume":"856","author":"Li","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0018","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/chromsci\/46.6.490","article-title":"Analysis of ciprofloxacin by a simple high-performance liquid chromatography method","volume":"46","author":"Wu","year":"2008","journal-title":"J Chromatograph Sci"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0019","doi-asserted-by":"crossref","first-page":"e4214","DOI":"10.1002\/bmc.4214","article-title":"Development and validation of a LC-MS\/MS method for quantitation of fosfomycin\u2014application to in vitro antimicrobial resistance study using hollow-fiber infection model","volume":"32","author":"Gandhi","year":"2018","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"10.1016\/j.ijantimicag.2019.105861_bib0020","doi-asserted-by":"crossref","first-page":"FSO349","DOI":"10.4155\/fsoa-2018-0055","article-title":"Combining LC-MS\/MS and hollow-fiber infection model for real-time quantitation of ampicillin to antimicrobial resistance","volume":"5","author":"Gandhi","year":"2018","journal-title":"Future Sci OA"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2019.105861_bib0021","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/infdis\/jiu610","article-title":"Pharmacokinetic\u2013pharmacodynamic and dose\u2013response relationships of antituberculosis drugs: recommendations and standards for industry and academia","volume":"211","author":"Gumbo","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01150-18","article-title":"Meropenem combined with ciprofloxacin combats hypermutable Pseudomonas aeruginosa from respiratory infections of cystic fibrosis patients","volume":"62","author":"Rees","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01815-17","article-title":"Evaluation of activity and emergence of resistance of polymyxin B and ZTI-01 (fosfomycin for injection) against KPC-producing Klebsiella pneumoniae","volume":"62","author":"Diep","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0024","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/AAC.00355-16","article-title":"Relationship between fosfomycin exposure and amplification of Escherichia coli subpopulations with reduced susceptibility in a hollow-fiber infection model","volume":"60","author":"VanScoy","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0025","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s10439-007-9306-x","article-title":"Modeling of microbial population responses to time-periodic concentrations of antibiotic agents","volume":"35","author":"Nikolaou","year":"2007","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0026","doi-asserted-by":"crossref","first-page":"e00540-17","DOI":"10.1128\/mBio.00540-17","article-title":"Polymyxin combinations combat Escherichia coli harboring mcr-1 and blaNDM-5: preparation for a postantibiotic era","volume":"8","author":"Bulman","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0027","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.0800944105","article-title":"Drugs interactions modulate the potential for evolution of resistance","volume":"105","author":"Michel","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0028","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-018-0278-9","article-title":"Species-specific activity of antibacterial drug combinations","volume":"559","author":"Brochado","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0029","doi-asserted-by":"crossref","first-page":"20160800","DOI":"10.1098\/rsif.2016.0800","article-title":"Uncovering emergent interactions in three-way combinations of stressors","volume":"13","author":"Beppler","year":"2016","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0030","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1073\/pnas.1606301113","article-title":"Prediction of multidimensional drug dose responses based on measurements of drug pairs","volume":"113","author":"Zimmer","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0031","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/S0021-9258(18)93392-2","article-title":"Biosynthesis of the peptidoglycan of bacterial cell walls","volume":"243","author":"Tipper","year":"1968","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0032","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1749-6632.1974.tb43277.x","article-title":"The mechanism of action of fosfomycin (phosphonomycin)","volume":"235","author":"Kahan","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0033","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jac\/dkg222","article-title":"Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection","volume":"51","author":"Ruiz","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0034","article-title":"Development of a broad-spectrum antimicrobial combination for the treatment of Staphylococcus aureus and Pseudomonas aeruginosa corneal infections","volume":"63","author":"Chojnacki","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","article-title":"Combination therapies for combating antimicrobial resistance","volume":"14","author":"Fischbach","year":"2011","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0036","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1475-2875-9-217","article-title":"Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty","volume":"9","author":"Smith","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0037","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1128\/AAC.00461-13","article-title":"Relationship between ceftolozane\u2013tazobactam exposure and drug resistance amplification in a hollow-fiber model","volume":"57","author":"VanScoy","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02013457","article-title":"Factors influencing the activity of the trometamol salt of fosfomycin","volume":"5","author":"Greenwood","year":"1986","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.105861_bib0039","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1038\/ncomms6792","article-title":"Prediction of antibiotic resistance by gene expression profiles","volume":"5","author":"Suzuki","year":"2014","journal-title":"Nat Commun"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919303322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919303322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:36:01Z","timestamp":1760376961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919303322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0924857919303322"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.105861","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.105861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105861"}}